Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$739K Buy
2,940
+984
+50% +$212K 0.05% 284
2026
Q1
$425K Buy
1,956
+358
+22% +$79.4K 0.03% 399
2025
Q4
$365K Sell
1,598
-20
-1% -$4.56K 0.03% 380
2025
Q3
$375K Buy
1,618
+40
+3% +$8.15K 0.04% 348
2025
Q2
$293K Sell
1,578
-75
-5% -$13.9K 0.03% 382
2025
Q1
$346K Buy
1,653
+41
+3% +$7.97K 0.04% 323
2024
Q4
$286K Sell
1,612
-12
-0.7% -$2.21K 0.04% 304
2024
Q3
$321K Buy
1,624
+87
+6% +$16.2K 0.04% 294
2024
Q2
$264K Buy
1,537
+61
+4% +$10.1K 0.04% 287
2024
Q1
$269K Sell
1,476
-97
-6% -$16.7K 0.04% 260
2023
Q4
$244K Buy
+1,573
New +$229K 0.04% 262
2021
Q1
Sell
-66
Closed -$7K 83
2020
Q4
$7K Buy
+66
New +$6.34K ﹤0.01% 554

Other funds holding ABBV

Inspire Advisors's ABBV Position: Q2 2026 in Review

Inspire Advisors increased its AbbVie (ABBV) stake by 50% in Q2 2026, buying an estimated $212K and bringing the position to 2,940 shares worth $739K. The position accounts for 0.05% of the portfolio, ranked #284.

Inspire Advisors first reported a position in ABBV in Q4 2020 and has held it in 12 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Inspire Advisors held 2,940 shares of AbbVie worth $739K as of Q2 2026.
  • Inspire Advisors bought 984 AbbVie shares in Q2 2026, an estimated $212K.
  • AbbVie made up 0.05% of Inspire Advisors's portfolio in Q2 2026, its #284 holding.
  • Inspire Advisors first reported a position in AbbVie in Q4 2020 and has held it in 12 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.